Anika Therapeutics Inc (ANIK)

Currency in USD
8.13
-0.09(-1.09%)
Real-time Data·
ANIK Scorecard
Full Analysis
Management has been aggressively buying back shares
ANIK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.118.29
52 wk Range
7.8726.99
Key Statistics
Prev. Close
8.22
Open
8.22
Day's Range
8.11-8.29
52 wk Range
7.87-26.99
Volume
31.73K
Average Volume (3m)
109.28K
1-Year Change
-68.32%
Book Value / Share
10.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANIK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.33
Upside
+113.20%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Anika Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Anika Therapeutics Inc Company Profile

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company’s joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Anika Therapeutics Inc Earnings Call Summary for Q2/2025

  • Q2 2025 revenue beat at $28.2M, but EPS missed at -$0.13; stock tumbled 23.21% to $10.5 in pre-market trading
  • Regenerative solutions segment grew 41% YoY; overall revenue down 8% YoY with gross margin declining 16 percentage points to 51%
  • Operating expenses reduced by 17%; company maintained 2025 adjusted EBITDA guidance between -3% and +3%
  • HYALOFAST full market release expected in 2028; $3M revenue projected by 2027
  • CEO emphasized data strength and outlined path for CINGAL NDA submission; pricing pressures in orthopedic pain management persist
Last Updated: 30/07/2025, 15:20
Read Full Transcript

Compare ANIK to Peers and Sector

Metrics to compare
ANIK
Peers
Sector
Relationship
P/E Ratio
−9.2x−0.4x−0.5x
PEG Ratio
−0.54−0.010.00
Price/Book
0.8x2.7x2.6x
Price / LTM Sales
1.0x8.7x3.3x
Upside (Analyst Target)
94.6%315.8%43.4%
Fair Value Upside
Unlock6.0%7.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 17.33
(+113.20% Upside)

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-0.13 / -0.08
Revenue / Forecast
28.22M / 28.15M
EPS Revisions
Last 90 days

ANIK Income Statement

People Also Watch

18.35
SRPT
+2.17%
5.17
REPL
-5.66%
9.085
CAPR
+12.58%
5.5500
BGLC
-1.94%
14.05
SLP
-0.07%

FAQ

What Stock Exchange Does Anika Trade On?

Anika is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Anika?

The stock symbol for Anika is "ANIK."

What Is the Anika Market Cap?

As of today, Anika market cap is 117.22M.

What Is Anika's Earnings Per Share (TTM)?

The Anika EPS (TTM) is -0.89.

When Is the Next Anika Earnings Date?

Anika will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is ANIK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Anika Stock Split?

Anika has split 0 times.

How Many Employees Does Anika Have?

Anika has 288 employees.

What is the current trading status of Anika (ANIK)?

As of 08 Aug 2025, Anika (ANIK) is trading at a price of 8.13, with a previous close of 8.22. The stock has fluctuated within a day range of 8.11 to 8.29, while its 52-week range spans from 7.87 to 26.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.